Glen Jeffery Selected Research

Glen Jeffery Research Topics

Disease

18	Macular Degeneration (Age-Related Maculopathy) 01/2021 - 07/2009
12	Inflammation (Inflammations) 01/2022 - 10/2012
7	Ganglion Cysts (Ganglion) 01/2022 - 05/2002
6	Retinal Degeneration 01/2019 - 04/2007
6	Albinism 02/2008 - 05/2002
3	Retinal Diseases 01/2017 - 03/2008
2	Atrophy 01/2022 - 06/2012
2	Aniridia 02/2008 - 10/2005
1	Gliosis 01/2018
1	Ocular Albinism 12/2017
1	Retinal Detachment (Retinal Detachments) 12/2017
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2016
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2016
1	Atherosclerosis 01/2016
1	Blindness (Hysterical Blindness) 10/2012
1	Vision Disorders (Hemeralopia) 07/2012
1	Parkinson Disease (Parkinson's Disease) 01/2012
1	Stargardt Disease 12/2011
1	Fundus Albipunctatus 12/2011
1	Burns 03/2010
1	Choroidal Neovascularization 07/2009
1	Retinal Dysplasia 05/2008
1	Retinal Dystrophies 03/2008
1	Vascular Remodeling 03/2008
1	Erectile Dysfunction 06/2007
1	Cone Dystrophy 09/2006
1	Hypopigmentation (Hypomelanosis) 05/2005
1	Oculocutaneous albinism type 1 08/2004
1	Congenital Abnormalities (Deformity) 08/2004

Drug/Important Bio-Agent (IBA)

30	Retinaldehyde (Retinal)IBA 01/2022 - 05/2002
9	Complement Factor H (Factor H)IBA 01/2021 - 07/2009
5	Amyloid beta-PeptidesIBA 01/2019 - 10/2010
5	Adenosine Triphosphate (ATP)IBA 01/2017 - 05/2014
4	melanopsinIBA 03/2008 - 05/2003
4	Monophenol Monooxygenase (Tyrosinase)IBA 02/2006 - 05/2002
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2013
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2013
3	Melanins (Melanin)IBA 12/2017 - 11/2005
3	Complement System Proteins (Complement)IBA 01/2016 - 07/2009
2	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 03/2015 - 01/2013
2	EnzymesIBA 06/2007 - 02/2006
1	CytokinesIBA 01/2022
1	NeuroglobinIBA 01/2022
1	Ion Pumps (Ion Pump)IBA 01/2017
1	IronIBA 10/2016
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2016
1	CyclodextrinsIBA 06/2015
1	SugarsIBA 06/2015
1	Ophthalmic Solutions (Eye Drops)IBA 06/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2014
1	Acrolein (Aqualin)IBA 05/2014
1	Mitochondrial DNA (mtDNA)IBA 05/2014
1	Free RadicalsIBA 05/2014
1	Amyloid (Amyloid Fibrils)IBA 08/2013
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 02/2013
1	Complement C3b (C3bi)IBA 02/2013
1	Complement C3d (Complement 3d)IBA 02/2013
1	Complement C3 (C3 Complement)IBA 01/2013
1	Vitamin D FDA LinkGeneric 10/2012
1	Cholecalciferol (Vitamin D3)FDA Link 10/2012
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2012
1	Glatiramer Acetate (Copaxone)FDA Link 11/2011
1	ElementsIBA 07/2009
1	Fluorescein (Funduscein)FDA LinkGeneric 07/2009
1	NucleotidesIBA 07/2009
1	Type 6 Cyclic Nucleotide PhosphodiesterasesIBA 06/2007
1	Sildenafil Citrate (Viagra)FDA Link 06/2007
1	short-wavelength opsinIBA 04/2007
1	OpsinsIBA 04/2007
1	PlasticsIBA 04/2007
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 09/2006
1	Tyrosine (L-Tyrosine)FDA Link 02/2006
1	Levodopa (L Dopa)FDA LinkGeneric 02/2006
1	dopaquinoneIBA 02/2006
1	Tetracycline (Achromycin)FDA LinkGeneric 08/2004
1	Retinal Pigments (Pigments, Visual)IBA 05/2002

Therapy/Procedure

3	Low-Level Light Therapy (LLLT) 04/2020 - 01/2012
3	Lasers (Laser) 01/2013 - 07/2009